Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
      Description

      The purpose of this study to find out whether codrituzumab is a safe treatment that causes few or mild side effects in children and young adults who have solid tumors that express the protein GPC3. The researchers also want to study the way codrituzumab is absorbed, distributed, and cleared from the body.

      Conditions
      Primary Extra-cranial Solid TumorRecurrent or Refractory Glypican 3 (GPC3)
      Talk to us